Trademarkia Logo

Canada

C$
Trademark Search in Canada
ROUKEN

View On IC.GC.CA

ROUKEN
FORMALIZED

on 1 May 2025

Last Applicant/ Owned by

Antibody Analytics Limited

Antibody Analytics Discovery Centre,Braidhurst Industrial,Motherwell, North Lanarkshire ML1 3ST

GB

Serial Number

2395901 filed on 26th Nov 2024

ROUKEN

Trademark usage description

chemicals used in industry and science; chemicals and reagents for scientific or medical research purposes; chemical preparations, substances and reag Read More

Classification Information

Class [001]
Chemicals used in industry and science; chemicals and reagents for scientific or medical research purposes; chemical preparations, substances and reagents for analysis in laboratories, not for medical or veterinary purposes; diagnostic preparations, not for medical or veterinary purposes; reagents used for research purposes including medical research; reagents used for chemical analyses; scientific reagents; chemicals for use in immunology; reagents used for immunoserology; diagnostic and testing reagents for scientific use; immunoassay reagents, other than for medical use; laboratory chemicals and reagents for scientific use and medical research; biochemicals; biochemicals being monoclonal antibodies; immunogens, immunoglobulins, antibodies, peptides and proteins for scientific and medical research services; biological activators, namely, preparations for clinical or medical laboratory use; biological preparations for use as assay samples for research analysis purposes in the field of medical research; reagents for use in scientific apparatus for chemical or biological analysis; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagents for scientific and research use; assays and reagents for use in genetic research; cell culture reagents for scientific and research use; protein for industrial use; protein in raw material form for scientific and medical research; assays for research purposes; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, DNA, RNA and oligonucleotides for in vitro research use; cells for scientific and research use; immune cells for scientific and research use; T cells for scientific and research use; primary cells for scientific and research use; immortalised cells for scientific and research use; biological tissue, namely, blood, stem cells, disease state tissue, healthy donor tissue, healthy donor blood, human biopsy tissue, umbilical cords and placentas for scientific and medical research use.

Classification kind code

12

Class [005]
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for medical purposes; large molecules for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for medical use; human biopsy tissue; biological preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases; biological and chemical preparations and reagents for medical or veterinary use; antiserums for diagnostic purposes; diagnostic reagents for medical use; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical use; diagnostic agents, preparations and substances for medical purposes; medical diagnostic reagents and assays for testing body fluids for microorganisms; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; antibodies for medical purposes; in-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; reagents for medical use; chemical reagents for medical purposes; reagents for use in medical genetic testing; enzymes for medical purposes; cells for medical or clinical use; culture media for cultivating human cells and microorganism cells; immunoassay reagents for medical use; assay platforms for medical use; immunology assays for medical use; antigens for medical use; T cells for medical use; immune cells; primary cells for medical and clinical use; immortalised cells for medical and clinical use; target antigens for medical use; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system for the treatment of inflammatory disorders for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; vaccine preparations; therapeutic vaccines; diagnostic preparations for clinical or medical laboratory use.

Classification kind code

12

Class [042]
Research and development services; laboratory services; research and development services in the field of antibodies and antibody technology; advisory services relating to chemical reagents; scientific and industrial research services; laboratory services namely, research, analysis, characterising, development and production of therapeutic proteins and human antibodies; development and design of scientific analytical testing methodologies; research into new drug candidates; industrial analysis and research services, in particular for selecting, characterising and preparing immunoglobulins, antibodies or parts thereof; research and development services in the field of immunology; identification of immunogenic sequences and peptides; sequence discovery services; immunotoxicology research and analysis services; immunogenicity research and analysis services; pharmaceutical drug development services; development of gene-based medicines; research and development of vaccines and medicines; biological cloning services; biological research and analysis; biological drug development services; medical laboratory services; laboratory research services relating to pharmaceuticals; providing laboratory research services in the field of biopharmaceuticals; chemical, biochemical, biological and bacteriological research and analysis; research and development services in the field of molecular science; analysis services in the field of molecular biology and molecular genetics; diagnostic services in the field of immunology; providing reagent sample testing and diagnostic services for others for scientific research purposes; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; providing information about medical research in the fields of biopharmaceuticals, immunology, cell engineering and immunoassays; consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; custom design and development of chemical reagents and biochemical assays; scientific research in the field of genetics and genetic engineering; genetic sequencing analysis services; analysis services regarding the safety and efficacy of new pharmaceuticals; research in the field of cell engineering technology; cell engineering services, namely cell suppression and cell activation; research, development, engineering and testing services in the fields of bioanalytical assays, assay development and antigen binding; research, development, engineering and testing services in the fields of immunotherapies, antibody-based molecules and targeted protein degraders; research, development, engineering and testing services in the fields of molecular biology, biophysics, DNA replication and replication of immune cell interaction in the tumour microenvironment; research, development, engineering and testing services in the field of biopharmaceutical modulating therapeutics; compiling and analysing data for research purposes in the field of medical science and medical consultancy; authentication of data in the field of immunology; cell culture services for scientific and research purposes, for others; DNA sequencing technology research; research, development, engineering and testing services in the fields of immunopharmaceuticals, vaccines and oncology; consultancy, information and advisory services relating to all of the aforesaid services.

Classification kind code

12

Mark Details

Serial Number

2395901

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 257
on 1st May 2025		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 1st May 2025		Created
Submitted for opposition 31
on 1st May 2025		Formalized
Submitted for opposition 30
on 26th Nov 2024		Filed
Submitted for opposition 228
on 26th Nov 2024		International Registration